
The L V Prasad Eye Institute in Hyderabad has secured a 20-year patent from the Indian government for a groundbreaking cell therapy designed to repair damaged corneas resulting from various corneal diseases. The treatment combines unique corneal stem cells with clotting factors to address corneal scarring, a leading cause of blindness. The patented composition could potentially revolutionize corneal pathology treatment, offering a promising alternative to complex and lifelong corneal transplants, with ongoing clinical trials showcasing its significant impact on ophthalmology and cell-based therapy.
Like
Save
Share